drugset / Trial / NCT05148000
Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
NaSingle-groupOpen-labelTreatment
Summary
This study to assess aesthetic improvement following treatment with QM1114-DP.
Timeline
- Start
- 2023-01-23
- Primary completion
- 2023-03-31
- Completion
- 2023-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin | Protein / enzyme biologic | — | — |